Trained immunity and the regulation of anti-fungal defense

训练有素的免疫力和抗真菌防御的调节

基本信息

  • 批准号:
    10557883
  • 负责人:
  • 金额:
    $ 63.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-01 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

Abstract: Although often overlooked as a significant health problem, pulmonary infections with fungal pathogens present a clinical problem of growing concern. Aspergillus fumigatus (Af) and Cryptococcus neoformans (Cn) are two clinically important fungal pathogens that affect immunosuppressed patients worldwide. Both infections are difficult to treat and are associated with high mortality rates. A better understanding of immune mechanisms of host defense against fungi hold the promise of providing the basis for the future development of novel, immune based interventions to improve patient outcomes. Pulmonary macrophages are critical, front-line mediators of host protection against fungi and other pulmonary pathogens. Despite the well-defined role of lung macrophages as crucial initiators of immunity to diverse sets of pathogens, our understanding of how previous infection history shapes subsequent macrophage responses to fungal infection in the lung remain poorly defined. Moreover, an emerging body of literature has now revealed that macrophage populations in the lung are more heterogeneous than originally appreciated and can undergo innate training; an enhanced response to diverse secondary challenges. It is now also understood that alveolar macrophages present in the lung can originate from embryonic precursors (tissue-derived alveolar macrophages-TD-AMs) or from blood monocytes (monocyte-derived alveolar macrophages-Mo-AMs). Whether TD-AM and Mo-AM are equally capable of undergoing innate training is currently unclear. It is also unknown whether innate training is a conserved response to any infectious stimuli or regulated by specific pathways. In preliminary studies, we uncovered that priming with an immunogenic strain of Cn (HK-fbp1) could confer heterologous protection against infection with Af even in the context of drug-induced immunosuppression and in a T cell-independent manner. Preliminary data gathered, suggest that neutrophils and STAT1-dependent signals are important regulators of antifungal monocytes and their differentiation into monocyte-derived cells. Based on our aggregate observations, the central hypothesis of this project is that: CCR2+mo are critical mediators of antifungal immunity and can be instructed by HK-fbp1 into trained mo-AM via the coordinated actions of neutrophils and an interferon (IFN) cascade. We will address two related but independent aims: Aim 1: Investigate the impact of HK-fbp1 immunization to pulmonary innate cell priming and training to promote antifungal immunity; Aim 2: Decipher the contributions of neutrophils in the regulation of antifungal trained immunity.
摘要: 虽然经常被忽视作为一个重大的健康问题,肺部感染的真菌病原体存在 一个日益受到关注的临床问题。烟曲霉(Af)和新型隐球菌(Cn)是两种 影响全球免疫抑制患者的临床重要真菌病原体。这两种感染都是 很难治疗并且死亡率很高。更好地了解免疫机制 宿主对真菌的防御有望为未来开发新的免疫 以改善患者的治疗效果。肺巨噬细胞是重要的, 保护宿主免受真菌和其他肺部病原体的侵害。尽管肺巨噬细胞的作用很明确, 作为对不同病原体免疫的关键启动者,我们对以前感染史的理解 形状随后巨噬细胞对肺部真菌感染的反应仍然不清楚。而且安 大量的文献显示,肺中的巨噬细胞群体更加异质 比最初欣赏的,可以接受先天训练;对不同的次要反应的增强反应 挑战现在还理解,存在于肺中的肺泡巨噬细胞可以起源于胚胎巨噬细胞。 前体细胞(组织来源的肺泡巨噬细胞-TD-AM)或来自血液单核细胞(单核细胞来源的肺泡巨噬细胞 巨噬细胞-Mo-AM)。TD-AM和Mo-AM是否同样能够进行先天训练, 目前不清楚。也不知道先天训练是否是对任何感染性刺激的保守反应, 由特定的途径调节。在初步研究中,我们发现,用免疫原性的 Cn(HK-fbp 1)即使在药物诱导的Af感染的情况下,也可以赋予针对Af感染的异源保护作用。 免疫抑制和T细胞非依赖性方式。初步数据显示,中性粒细胞 和STAT 1依赖性信号是抗真菌单核细胞的重要调节因子, 单核细胞衍生的细胞。根据我们的综合观察,本项目的中心假设是: CCR 2 +mo是抗真菌免疫的关键介质,可以由HK-fbp 1通过以下方式指导经过训练的mo-AM 中性粒细胞和干扰素(IFN)级联的协调作用。我们将讨论两个相关的问题, 独立目的:目的1:研究HK-fbp 1免疫对肺先天性细胞引发的影响, 训练,以促进抗真菌免疫;目的2:破译中性粒细胞在调节 抗真菌训练免疫力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amariliz Rivera其他文献

Amariliz Rivera的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amariliz Rivera', 18)}}的其他基金

Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
  • 批准号:
    10793773
  • 财政年份:
    2019
  • 资助金额:
    $ 63.08万
  • 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
  • 批准号:
    10574561
  • 财政年份:
    2019
  • 资助金额:
    $ 63.08万
  • 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
  • 批准号:
    10542652
  • 财政年份:
    2019
  • 资助金额:
    $ 63.08万
  • 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
  • 批准号:
    10097978
  • 财政年份:
    2019
  • 资助金额:
    $ 63.08万
  • 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
  • 批准号:
    10335166
  • 财政年份:
    2019
  • 资助金额:
    $ 63.08万
  • 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
  • 批准号:
    9886185
  • 财政年份:
    2019
  • 资助金额:
    $ 63.08万
  • 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
  • 批准号:
    10274411
  • 财政年份:
    2019
  • 资助金额:
    $ 63.08万
  • 项目类别:
Regulation of antifungal immunity by monocyte-derived dendritic cells
单核细胞来源的树突状细胞抗真菌免疫的调节
  • 批准号:
    9263884
  • 财政年份:
    2015
  • 资助金额:
    $ 63.08万
  • 项目类别:
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
CCR2 单核细胞和 Mo-DC 在防御 IA 和 GVHD 发展中的作用
  • 批准号:
    8701013
  • 财政年份:
    2013
  • 资助金额:
    $ 63.08万
  • 项目类别:
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
CCR2 单核细胞和 Mo-DC 在防御 IA 和 GVHD 发展中的作用
  • 批准号:
    8637016
  • 财政年份:
    2013
  • 资助金额:
    $ 63.08万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.08万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了